Data as of Jan 23
| -1.92 / -2.75%|
The 18 analysts offering 12-month price forecasts for LifePoint Hospitals Inc have a median target of 80.50, with a high estimate of 94.00 and a low estimate of 70.00. The median estimate represents a +18.42% increase from the last price of 67.98.
The current consensus among 23 polled investment analysts is to Hold stock in LifePoint Hospitals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.